Drug Profile
Research programme: trophic factor biotherapeutics - Mesoblast
Alternative Names: Cytokine biotherapeutics - Mesoblast; SDF-1 - Mesoblast; Stromal derived factor-1 - MesoblastLatest Information Update: 28 Mar 2023
Price :
$50
*
At a glance
- Originator Mesoblast
- Class CXC chemokines; Peptides; Small molecules
- Mechanism of Action Angiogenesis inducing agents; CXCR4 receptor agonists; Leukocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 28 Mar 2023 Discontinued - Preclinical for Cardiovascular disorders in Australia (unspecified route)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Cardiovascular-disorders in Australia
- 29 Jan 2014 Preclinical trials in Cardiovascular disorders in Australia (unspecified route)